Lifeboat Foundation

“Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference…” “…Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections.”

Vaccine. 2020 Jan 10;38:350–354. doi: 10.1016/j.vaccine.2019.10.005. Epub 2019 Oct 10.

PURPOSE: Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined.

Continue reading “Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. — PubMed — NCBI” »

The Curiosity rover analyzes compounds by breaking them down into fragments. The upcoming European Space Agency’s Rosalind Franklin rover, however, could fill in the gaps with its Mars Organic Molecule Analyzer (MOMA), which doesn’t use the same destructive technique as Curiosity.

What has Schulze-Makuch most excited is the possibility of finding differing ratios of heavy and light isotopes in compounds, the result of organisms breaking down elements and “a telltale signal for life,” according to the researcher.

“As Carl Sagan said ‘extraordinary claims require extraordinary evidence,’” Schulze-Makuch said. “I think the proof will really require that we actually send people there, and an astronaut looks through a microscope and sees a moving microbe.”

A lightweight liquid metal alloy that is less dense than water could be used to make exoskeletons and transformable flexible robots.

Florida State University physicists believe they have an answer to unusual incidents of rare decay of a subatomic particle called a Kaon that were reported last year by scientists in the KOTO experiment at the Japan Proton Accelerator Research Complex.

FSU Associate Professor of Physics Takemichi Okui and Assistant Professor of Physics Kohsaku Tobioka published a new paper in the journal Physical Review Letters that proposes that this decay is actually a new, short-lived particle that has avoided detection in similar experiments.

“This is such a rare disintegration,” Okui said. “It’s so rare, that they should not have seen any. But if this is correct, how do we explain it? We think this is one possibility.”

https://www.youtube.com/watch?v=sdLyUZnGKGY&feature=youtu.be

The largest private automaker in China is getting into the satellite business. Chinese automotive giant Geely has broadened its reach to include everything from trucking, to high-speed trains, to passenger drones, to Volvo over the last decade or so. But its newest effort could tie those things all together, as Geely just announced it’s going to build its own satellite network to enable what it calls a “smart three-dimensional mobility ecosystem.”

Geely announced late Monday that it will erect a satellite production facility and testing center in the port city of Taizhou in the Zhejiang province that the Chinese giant calls home. The facility will be capable of building a “variety of different satellite models,” some of which may be for non-Geely entities.

Geely says it will start launching the satellite network as soon as the end of this year, but did not say how big it will be. Reuters reports that the company is pumping around $326 million into the project, and will eventually make 500 satellites a year.

An ultra-charismatic CEO and a company that wants to do just about everything.

Scientists say they have used the gene editing tool CRISPR inside someone’s body for the first time, a new frontier for efforts to operate on DNA, the chemical code of life, to treat diseases.

A patient recently had it done at the Casey Eye Institute at Oregon Health & Science University in Portland for an inherited form of blindness, the companies that make the treatment announced Wednesday. They would not give details on the patient or when the surgery occurred.

It may take up to a month to see if it worked to restore vision. If the first few attempts seem safe, doctors plan to test it on 18 children and adults.

In Beilinson Hospital, for the first time, a lung cancer patient went under surgery in which the tumor removed and the healthy lung returned to his body. “Cleaning” organs from tumors may change global coping with cancer.